On July 7, 2026, the United States Patent and Trademark Office published a groundbreaking patent (U.S. Patent No. 12672884) assigned to BIOPOLY, LLC. The patent, titled “Toe implant assemblies, kits, surgical methods, and methods of manufacturing,” outlines a novel approach to treating hallux rigidus and other painful conditions of the first metatarsophalangeal joint. By focusing on a minimally invasive and anatomically precise solution, the Fort Wayne, Indiana company is setting a new standard in orthopedic care for patients suffering from cartilage degradation.

This medical advancement introduces an elegant toe implant assembly that includes a specialized bearing member and a fixation member. The true genius of the design from BIOPOLY, LLC lies in its comprehensive surgical kit, which features a cannulated drill and unique sizing devices. These tools allow surgeons to operate with unprecedented precision, ensuring the implant conforms perfectly to the resected bone without the need for extensive joint destruction or traditional fusion techniques.

Why This Invention is Highly Innovative

The core innovation of this patent revolves around the geometric relationship between the implant components and the proprietary surgical methodology. The fixation member features a platform portion with a peripheral diameter that is carefully sized to be less than or equal to the peripheral diameter of the bearing member. This specific configuration prevents implant overhang and distributes weight loads evenly across the joint. Furthermore, the specialized surgical kit utilizes a guide pin and a cannulated drill system to form a highly accurate cavity. This method preserves much more natural bone stock compared to traditional joint replacement surgeries. Patients receive immediate structural support while retaining natural joint motion, minimizing the risk of complications such as subsidence or hardware failure.

Indiana State Patent of the Month for August 2026

Thanks to this remarkable contribution to orthopedic medicine, the invention was awarded the Indiana State Patent of the Month for August 2026. The state recognized BioPoly for its ongoing dedication to expanding Indiana’s reputation as a premier hub for life sciences and medical device manufacturing. The award committee highlighted the implant’s potential to dramatically improve the quality of life for aging and active populations alike, solidifying the company’s position as a regional and national leader in biomaterial engineering and surgical innovation.

R&D Tax Credit Eligibility in the USA

The practical applications of this patent make the underlying development work highly eligible for the Research and Development (R&D) tax credit in the United States. To claim this federal credit under Section 41 of the Internal Revenue Code, a company must demonstrate that it engaged in resolving technological uncertainties through a rigorous process of experimentation. Developing these specialized toe implant assemblies undoubtedly required extensive iterative prototyping, mechanical stress testing, and clinical evaluations to perfect the fit and function of the bearing and fixation members. Furthermore, the engineering of the custom cannulated drills and sizing devices directly constitutes qualified research activities. By thoroughly documenting the time and resources spent evaluating different design alternatives, material compositions, and surgical protocols, the developers can successfully qualify for the R&D tax credit. This powerful financial incentive allows medical device companies to offset significant development costs, ultimately encouraging continued domestic investment in advanced medical technologies.